As the industry continues to learn, innovate and continues to march forward with its adoption of a decentralized model, it is critical to continue evolving the technology. By applying a strategic approach to innovation, you can discern and leverage the necessary and beneficial shifts for the next generation of clinical trials.
The mission of the
NextGen Clinical Trials Innovation Summit is to provide attendees with the necessary innovative tools to tackle the most frequently identified reasons for trial failure such as study design, diversity in clinical trials, site selection, inadequate recruitment, patient burden or safety issues, and share best practices on how to conduct a high level of trial design and management to ensure cost-effective use of time and budgetary resources so that targets are met without compromising data integrity and regulatory compliance.
Our expert speaking faculty will address the opportunities for using digital biomarkers, remote healthcare, including conducting virtual or decentralized trials in the midst of the pandemic. The main challenges technology can address within insufficient patient enrollment, long clinical trial timelines due to inefficient data management, lack of evidence on patient outcomes, and low clinical trial success rate.
Top 5 Reasons to Attend
- Executing adaptive trials to increase flexibility of clinical trials enabling parameters such as sample size, patient population, and dosing to be adjusted as the trial progresses
- Integrating a reimbursement strategy into the drug development strategy to collect evidence useful in negotiation with payers
- Improving the health of all people, widening data points, and improving customer experience by increasing diversity in clinical trials
- Leading the industry by engaging patients in Decentralized Clinical Trials to reduce the scheduling and travel burden on patients and expedite the trial
- Implementing AI and Machine Learning to positively transform your clinical trials
Who Should Attend
- Clinical Research
- Clinical Operations
- Clinical Outsourcing
- Clinical Affairs
- Clinical Development
- Early Phase Research/Development
- Pharmacology/Pharmacokinetics/
- Pharmacodynamics
- Pharmacovigilance
- Translational/Experimental Science/Medicine
- Biostatistics/Biometrics
- Pharmacometrics
- Clinical Data Management/Statistics
- Clinical Innovation
- Regulatory Affairs/Compliance
- Medical Research/Affairs
- Patient Recruitment/Engagement
- Drug Safety
- Clinical Trial Manager
- Clinical Trials Associate
- Research Scientist
- Business Development
- Clinical Trial Design and Development
- Study Endpoint Development
- Clinical Research, Operations, Site Selection, and Management
- Research and Development
- Clinical Monitoring and Oversight
- Quality Management
- Contracts Management
- Clinical Data Management
- Data and Biostatistical Sciences
- Health Economics and Outcomes Research
- eClinical Technology and Solutions
- Digital Strategies and Technologies
- Data Analytics, Strategy, and Technology
- Information Technology, Systems, and Programming
- Regulatory Affairs
- Patient Engagement, Recruitment, and Retention
- Patient Advocacy, Partnerships, and Services
- Legal and Compliance
- Ethics, IRBs
- Medical Affairs and Communications
- Head Early Clinical Development
- Clinical Site Managers
Networking Capabilities
- Virtual Matchmaking: Visit our virtual lobby and connect with fellow attendees using our platform’s matchmaking technology. You can chat, video, and even make a list of the people you want to meet and the knowledge you’re looking to gain through our bespoke 1:1 match-making services.
- Roundtable Networking throughout the Summit will give you the chance to connect and meet in-depth your fellow attendees as well as our Sponsors and Speakers.
- The platform we use allows us to make polls, QA, and chat during the sessions.
- Virtual Happy Hour: Grab a drink and bring it to your screen to cheers from afar while continuing to chat with and get to know your fellow conference participants.
Speakers
- Susan Manoff, Executive Director, Vaccines and Infectious Diseases | Office of the Chief Patient Officer - Merck
- Andrew Rosen, Medical Director, Field - Akcea Therapeutics
- LaShell Robinson, Clinical Di In Clinical Trials Operations Lead - Johnson & Johnson
- Philip Harder Delff, Associate Director - Vertex Pharmaceuticals
- Chad Swanson, Director, Clinical Neuroscience - Eisai
- Jill Kearney, Global Operations Onco Ed Head - Janssen
- Ubong Peters, Operations Insights Analyst - Genentech
- Adaoma Aigbodion, Sr. Clinical Trial Monitor - Bristol-Myers Squibb
- Darya Rose, Managed Markets Marketing - GILEAD SCIENCES
- Debiprasad Roy, Technology, Data Science, Bioinformatics & Programming Head of Research & Development - ALLOGENE THERAPEUTICS
- Michael Frank, Senior Director, Breakthrough Change Studio - PFIZER
- Shameer Khader, Senior Director (Data Science, AI/ML, Digital Health & Bioinformatics) - ASTRAZENECA
- Mary Westrick, Adjunct Faculty (Phase I Clinical Trials Specialty) - UNIVERSITY OF WISCONSIN - MADISON
- Susmita Gupta, Clinical Scientist Consultant - CALITHERA BIOSCIENCES
- Vanja Vlajnic, Sr. Manager, Statistics and Data Insights - BAYER
- David Hamilton, Associate Director, Clinical Development and Analytics, Strategy and Operations - NOVARTIS
- John Caminis, Therapeutic Area Head I&I - GENZYME
- Howard Jan, CMC Project Manager, Pharma Technical Development - ROCHE
- Eskouhie Tchaparian, Preclinical and Early Clinical Development - HOLY STONE
Please fill in your name and email to receive the Virtual Summit Agenda of this event.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
